Press Releases

Press Releases

February 4, 2019
Surface Oncology Retains Worldwide Rights for its First-in-Class Antibody Targeting IL-27, SRF388
January 16, 2019
Publication in ImmunoHorizons Highlights the Role of IL-27 in Upregulation of Multiple Checkpoint Proteins
January 4, 2019
Surface Oncology Announces Appointment of F. Stephen Hodi, MD to its Scientific Advisory Board